Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis

The advancement of high-throughput sequencing and genomic analysis revealed that acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease. The abundance of such genetic data in ALL can also be utilized to identify potential targets for drug discovery and even drug repurposing. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zazuli, Zulfan, Irham, Lalu Muhammad, Adikusuma, Wirawan, Sari, Nur Melani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786277/
https://www.ncbi.nlm.nih.gov/pubmed/36559013
http://dx.doi.org/10.3390/ph15121562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786277/
https://www.ncbi.nlm.nih.gov/pubmed/36559013
http://dx.doi.org/10.3390/ph15121562

Ejemplares similares